Editorial: Novel Treatment Strategies for Myeloproliferative Neoplasms

Frontiers in Oncology

卷:11

Ken-Hong Lim²  Shinobu Matsuura³  Bing Xu⁵ 

[1] Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China;

[2] Department of Medicine, MacKay Medical College, New Taipei City, Taiwan;

[3] Department of Medicine–Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA, United States;

[4] Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei City, Taiwan;

[5] Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, China;

关键词: myeloproliferative neoplasms;    chronic myeloid leukemia;    CALR;    MPL;    tyrosine kinase inhibitor;   

DOI  :  10.3389/fonc.2021.762928

来源: DOAJ

【 授权许可】

Unknown